Showing results (1701-1710 of 2,248) with videos related to
Sort By:
Pageof 225
The Journal of Extra-Corporeal Technology|December 9, 1992
Extracorporeal support with a cadaver liver as a bridge to transplantationL W Fristoe, J H Merrill, J A Kangas, et al.Stroke|December 7, 2002
Long-term outcome after angioplasty for symptomatic extracranial carotid stenosis in poor surgical candidatesDouglas J Fox, Christopher J Moran, DeWitte T Cross, et al.Journal of Vascular Surgery|July 11, 2006
Delayed evaluation of combat-related penetrating neck traumaCharles J Fox, David L Gillespie, Michael A Weber, et al.International Journal of Medical and Biological Frontiers|November 11, 2014
Suicidal Ideation Associated with PCL Checklist-Ascertained PTSD among Veterans Treated for Substance AbuseJack R Cornelius, Gretchen L Haas, Cathleen J Appelt, et al.Journal of Neurophysiology|August 25, 2017
Anatomy and physiology of phrenic afferent neuronsJayakrishnan Nair, Kristi A Streeter, Sara M F Turner, et al.Neurodegenerative Disease Management|February 1, 2021
CLICK-MS and MASTER-2 Phase IV trial design: cladribine tablets in suboptimally controlled relapsing multiple sclerosisAugusto A Miravalle, Joshua Katz, Derrick Robertson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2010
Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancerGustavo S P Meirelles, Heiko Schöder, Gregory C Ravizzini, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Virus-associated tumor imaging by induction of viral gene expressionDe-Xue Fu, Yvette C Tanhehco, Jianmeng Chen, et al.Journal of Applied Microbiology|August 5, 2022
Norovirus attribution study: Detection of norovirus from the commercial food preparation environment in outbreak and non-outbreak premisesNicola C Elviss, David J Allen, Daniel Kelly, et al.Multiple Sclerosis and Related Disorders|May 27, 2015
Risk tolerance to MS therapies: Survey results from the NARCOMS registryRobert J Fox, Amber Salter, Joan M Alster, et al.Pageof 225